Cargando…

Substitution at Aspartic Acid 1128 in the SARS Coronavirus Spike Glycoprotein Mediates Escape from a S2 Domain-Targeting Neutralizing Monoclonal Antibody

The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) is the etiological agent for the infectious disease, SARS, which first emerged 10 years ago. SARS-CoV is a zoonotic virus that has crossed the species barriers to infect humans. Bats, which harbour a diverse pool of SARS-like CoVs (SL-CoVs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ng, Oi-Wing, Keng, Choong-Tat, Leung, Cynthia Sau-Wai, Peiris, J. S. Malik, Poon, Leo Lit Man, Tan, Yee-Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097068/ https://www.ncbi.nlm.nih.gov/pubmed/25019613 http://dx.doi.org/10.1371/journal.pone.0102415

Ejemplares similares

SARS coronavirus 8b reduces viral replication by down-regulating E via an ubiquitin-independent proteasome pathway
por: Keng, Choong-Tat, et al.
Publicado: (2011)

Performance Report, MD 1128 - 29.5.80
por: Lemeilleur, F
Publicado: (1980)

Dosimétrie autour de l'intersection 8 (Run 1128)
por: Bouriot, P, et al.
Publicado: (1980)

SG-APSIC1128: BHQ instrument management at Bangkok Hospital
por: Chomrak, Rome
Publicado: (2023)

Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein
por: Bordoloi, Devivasha, et al.
Publicado: (2021)

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
por: McCarthy, Kevin R., et al.
Publicado: (2021)

The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies
por: Focosi, Daniele, et al.
Publicado: (2022)

Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants
por: ter Meulen, Jan, et al.
Publicado: (2006)

The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape
por: Souza, Pedro F.N., et al.
Publicado: (2022)

1128. Utility of Anaerobic and Fungal Blood Cultures in the Pediatric Oncologic Population
por: Kumar, Madan, et al.
Publicado: (2018)

Radiographic Measurements on Hindfoot Alignment View in 1,128 Asymptomatic Subjects
por: Choi, Jun Young, et al.
Publicado: (2020)

The distribution and mutagenesis of short coding INDELs from 1,128 whole exomes
por: Challis, Danny, et al.
Publicado: (2015)

1128. Knowledge, Attitudes and Perceptions about Antibiotic Stewardship (AS) Programs among Neonatology Trainees
por: Akinboyo, Ibukunoluwa C, et al.
Publicado: (2019)

Emergence and Spread of a B.1.1.28-Derived P.6 Lineage with Q675H and Q677H Spike Mutations in Uruguay
por: Rego, Natalia, et al.
Publicado: (2021)

Increased Stability of SARS-CoV-2 Omicron Variant over Ancestral Strain
por: Chin, Alex Wing Hong, et al.
Publicado: (2022)

A single amino acid substitution in the S1 and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV
por: Mitsuki, Yu-ya, et al.
Publicado: (2008)

d-Amino Acid Peptide Residualizing Agents for Protein Radioiodination: Effect of Aspartate for Glutamate Substitution
por: Pruszynski, Marek, et al.
Publicado: (2018)

The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2
por: Benton, Donald J., et al.
Publicado: (2021)

Molecular rationale for SARS-CoV-2 spike circulating mutations able to escape bamlanivimab and etesevimab monoclonal antibodies
por: Laurini, Erik, et al.
Publicado: (2021)

Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies
por: Ding, Chengchao, et al.
Publicado: (2021)

Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes
por: Cheng, Lin, et al.
Publicado: (2021)

Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape
por: Krey, Thomas, et al.
Publicado: (2013)

1128. Online Spaced Education to Teach Microbiology to Medical Students in a Threaded Medical School Curriculum
por: Sathe, Nishad, et al.
Publicado: (2020)

Expression of SARS-coronavirus spike glycoprotein in Pichia pastoris
por: Chuck, Chi-Pang, et al.
Publicado: (2008)

Escape From Monoclonal Antibody Neutralization Affects Henipavirus Fitness In Vitro and In Vivo
por: Borisevich, Viktoriya, et al.
Publicado: (2016)

Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies Therapies
por: Jary, Aude, et al.
Publicado: (2022)

Identification of the immunodominant neutralizing regions in the spike glycoprotein of porcine deltacoronavirus
por: Chen, Rui, et al.
Publicado: (2020)

1128 Association between Cytomegalovirus Seropositivity or Titres and Cardiovascular Disease: Systematic Review and Meta-Analysis of Prospective Evidence
por: Ali, Mohsin, et al.
Publicado: (2014)

1128. Efficacy and Safety of Nelfinavir in Asymptomatic and Mild COVID-19 Patients: A Multicenter, Randomized Controlled Trial
por: Kohno, Shigeru, et al.
Publicado: (2022)

Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, British Columbia, Canada
por: Matic, Nancy, et al.
Publicado: (2021)

Amino acid substitutions and an insertion in the spike glycoprotein extend the host range of the murine coronavirus MHV-A59
por: Thackray, Larissa B, et al.
Publicado: (2004)

Comparison of bovine coronavirus (BCV) antigens: Monoclonal antibodies to the spike glycoprotein distinguish between vaccine and wild-type strains
por: Hussain, Khalid A., et al.
Publicado: (1991)

Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail
por: Addetia, Amin, et al.
Publicado: (2022)

Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail
por: Addetia, Amin, et al.
Publicado: (2023)

Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model
por: Duehr, James, et al.
Publicado: (2020)

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
por: Weisblum, Yiska, et al.
Publicado: (2020)

Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies
por: Alenquer, Marta, et al.
Publicado: (2021)

Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins
por: Liu, Xiao-Qin, et al.
Publicado: (2018)

Vacuum test in ring 1 (54 A, 50 A), Run 1128 MD, 29th May 1980
por: Hilleret, Noël, et al.
Publicado: (1980)

High Variability in Oral Glucose Tolerance among 1,128 Patients with Cystic Fibrosis: A Multicenter Screening Study
por: Scheuing, Nicole, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0iq7gjb8ai2qhffplpba76sdks